News

Christian Behrenbruch, CEO of ImaginAb, said: “ImaginAb is pleased to have formalised this collaboration with the GSK CIC. Not only does GSK have an excellent biologics pipeline, but

InVasc Therapeutics said that one grant is to continue research and development of small molecule drugs for the prevention and treatment of hypertension and stroke based on derivatives

The results demonstrated anti-tumor immunity of oncolytic viruses and indicated strong efficacy of the viruses against solid tumor cancers. Untill now 200 patients have been treated with oncolytic

The findings, presented by Boehringer Ingelheim Pharmaceuticals at the 58th Annual Clinical Meeting of the American College of Obstetricians and Gynecologists in San Francisco, include data from a

Vect-Horus has revealed the publication of its first patent in the ‘Institut National de la Propriété Intellectuelle’ (INPI) on April 23, 2010 (publication number FR2937322). The patent aims

Phoenix’s initial product launches in North America are expected to include private label finished goods using its antibiotic APIs, such as bacitracin and polymyxin B sulfate, two of

The data were presented at the American Thoracic Society 2010 International Conference in New Orleans, LA by Geron collaborator Claude Jourdan Le Saux from the University of Texas

LICR stated has partnered with Cancer Research Institute to establish the Cancer Vaccine Collaborative, a coordinated global network of laboratory and clinical sites with expertise in immunology, to

The randomised, double-blind, placebo-controlled, parallel-group, Phase II study was conducted in 25 centers across US, Canada, Europe and Israel and included 559 patients with ALS. In the trial,